SLIM: combined effects of Slo-Niacin and atorvastatin on lipoproteins and inflammatory markers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Atorvastatin; Niacin
- Indications Hyperlipidaemia
- Focus Biomarker; Pharmacodynamics
- Acronyms SLIM
- 28 Oct 2009 Results were published in the Journal of Clinical Lipidology, according to an Upsher-Smith media release.
- 21 Aug 2008 Biomarkers information updated
- 30 Oct 2007 Status changed from in progress to completed.